Underdiagnosis of lipodystrophy and rare insulin-resistance syndromes is an important issue, due to the heterogeneous clinical presentation of patients, the lack of highly specific clinical signs and markers, and the lack of widespread medical knowledge regarding adipose tissue dysfunction and rare disorders of insulin sensitivity [6]. The gene discussed is INS; the disease is lipodystrophy.